Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of brain morphology (HP:0012443)help
Grandparent Node:
expand
Abnormality of the vasculature (HP:0002597)help
Parent Node:
expand
Abnormal cerebral vascular morphology (HP:0100659)help
..Starting node
..expand
Stroke (HP:0001297)help
Term ID: 1297
Name: Stroke
Synonym: Cerebral vascular events; Cerebrovascular accident; Cerebrovascular accidents; Stroke
Definition: Sudden impairment of blood flow to a part of the brain due to occlusion or rupture of an artery to the brain.
Comments:
Reference: HP:0001297
Genes and Diseases:
 
       Child Nodes:
........expandIschemic stroke (HP:0002140) help
........expandTransient ischemic attack (HP:0002326) help
........expandStroke-like episode (HP:0002401) help

 Sister Nodes: 
..expandAbnormal cerebral artery morphology (HP:0009145) help
..expandAbnormal cerebral vein morphology (HP:0012480) help
..expandCerebral arteriovenous malformation (HP:0002408) help
..expandCerebral vasculitis (HP:0005318) help
..expandDilation of Virchow-Robin spaces (HP:0012520) help
..expandIntracranial hemorrhage (HP:0002170) help
InputHPO IDHPO termDistanceGeneGene id entrezDiseaseIdDiseaseNameDiseaseMIMConceptIDSourceTypical associationHGMD variantsClinVar variantsHGNC IDGeneMIM
 
HPO disease - gene - phenotype typical associations:
HP:0001297HP:0001297Stroke0ABCC6 CL E G H368264800Pseudoxanthoma elasticum264800C0033847OMIM1166657603234
HP:0001297HP:0001297Stroke0ACAD9 CL E G H28976611126Acyl-CoA dehydrogenase family, member 9, deficiency of611126C1970173OMIM177121497611103
HP:0001297HP:0001297Stroke0ADA2 CL E G H51816182410Idiopathic livedo reticularis with systemic involvement182410C0282492OMIM15331839607575
HP:0001297HP:0001297Stroke0APP CL E G H351324708ORPHA1506620104760
HP:0001297HP:0001297Stroke0APP CL E G H351324713ORPHA1506620104760
HP:0001297HP:0001297Stroke0APP CL E G H351324703ORPHA1506620104760
HP:0001297HP:0001297Stroke0APP CL E G H351100006ORPHA1506620104760
HP:0001297HP:0001297Stroke0APP CL E G H351605714Cerebral amyloid angiopathy, APP-related605714C2751536OMIM1506620104760
HP:0001297HP:0001297Stroke0BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA1249961605681
HP:0001297HP:0001297Stroke0CBS CL E G H875236200Homocystinuria due to CBS deficiency236200C3150344OMIM111201550613381
HP:0001297HP:0001297Stroke0CCM2 CL E G H83605603284Cerebral cavernous malformations 2603284C1864041OMIM131021708607929
HP:0001297HP:0001297Stroke0CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA12292586603432
HP:0001297HP:0001297Stroke0CST3 CL E G H1471100008ORPHA1542475604312
HP:0001297HP:0001297Stroke0CST3 CL E G H1471105150Hereditary cerebral amyloid angiopathy, Icelandic type105150C1527338OMIM1542475604312
HP:0001297HP:0001297Stroke0ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA19663327130160
HP:0001297HP:0001297Stroke0FLNA CL E G H2316300049Periventricular nodular heterotopia 1300049C1848213OMIM130333754300017
HP:0001297HP:0001297Stroke0GNAQ CL E G H27763205LBWD syndromeORPHA1914390600998
HP:0001297HP:0001297Stroke0GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA11784659601679
HP:0001297HP:0001297Stroke0GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA12664661604318
HP:0001297HP:0001297Stroke0GUCY1A1 CL E G H2982401945ORPHA11024685139396
HP:0001297HP:0001297Stroke0GYS1 CL E G H2997611556Glycogen storage disease 0, muscle611556C1969054OMIM16074706138570
HP:0001297HP:0001297Stroke0HBB CL E G H3043603903Hb SS disease603903C0002895OMIM116004827141900
HP:0001297HP:0001297Stroke0HTRA1 CL E G H5654600142Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy600142C1838577OMIM12859476602194
HP:0001297HP:0001297Stroke0JAG1 CL E G H182118450Alagille syndrome 1118450C1956125OMIM116056188601920
HP:0001297HP:0001297Stroke0KCNQ1 CL E G H3784607554Atrial fibrillation, familial, 3607554C1837014OMIM122006294607542
HP:0001297HP:0001297Stroke0LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA12326613601329
HP:0001297HP:0001297Stroke0MTHFR CL E G H4524236250Homocysteinemia due to MTHFR deficiency236250C1856058OMIM17247436607093
HP:0001297HP:0001297Stroke0NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM113437883600276
HP:0001297HP:0001297Stroke0NPPA CL E G H4878615745Atrial standstill 2615745C3810401OMIM11827939108780
HP:0001297HP:0001297Stroke0PRKAG2 CL E G H51422194200Wolff-Parkinson-White pattern194200C0043202OMIM110799386602743
HP:0001297HP:0001297Stroke0RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA12009970600404
HP:0001297HP:0001297Stroke0SCN5A CL E G H6331601154Dilated cardiomyopathy 1E601154C1832680OMIM1353110593600163
HP:0001297HP:0001297Stroke0TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA119411586605842
HP:0001297HP:0001297Stroke0TPP2 CL E G H7174444463ORPHA162512016190470
HP:0001297HP:0001297Stroke0TREX1 CL E G H11277247691ORPHA141812269606609
HP:0001297HP:0001297Stroke0TREX1 CL E G H11277192315Vasculopathy, retinal, with cerebral leukodystrophy192315C1860518OMIM141812269606609
HP:0001297HP:0001297Stroke0VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM1180512687608537
HP:0001297HP:0002401Stroke-like episode1ABCC6 CL E G H368264800Pseudoxanthoma elasticum264800C0033847OMIM1166657603234
HP:0001297HP:0033762Middle cerebral artery stroke1ABCC6 CL E G H368264800Pseudoxanthoma elasticum264800C0033847OMIM1166657603234
HP:0001297HP:0002140Ischemic stroke1ABCC6 CL E G H368264800Pseudoxanthoma elasticum264800C0033847OMIM1166657603234
HP:0001297HP:0002326Transient ischemic attack1ABCC6 CL E G H368264800Pseudoxanthoma elasticum264800C0033847OMIM1166657603234
HP:0001297HP:0002401Stroke-like episode1ACAD9 CL E G H28976611126Acyl-CoA dehydrogenase family, member 9, deficiency of611126C1970173OMIM177121497611103
HP:0001297HP:0002140Ischemic stroke1ACAD9 CL E G H28976611126Acyl-CoA dehydrogenase family, member 9, deficiency of611126C1970173OMIM177121497611103
HP:0001297HP:0033762Middle cerebral artery stroke1ACAD9 CL E G H28976611126Acyl-CoA dehydrogenase family, member 9, deficiency of611126C1970173OMIM177121497611103
HP:0001297HP:0002326Transient ischemic attack1ACAD9 CL E G H28976611126Acyl-CoA dehydrogenase family, member 9, deficiency of611126C1970173OMIM177121497611103
HP:0001297HP:0002401Stroke-like episode1ADA2 CL E G H51816182410Idiopathic livedo reticularis with systemic involvement182410C0282492OMIM15331839607575
HP:0001297HP:0002140Ischemic stroke1ADA2 CL E G H51816182410Idiopathic livedo reticularis with systemic involvement182410C0282492OMIM15331839607575
HP:0001297HP:0033762Middle cerebral artery stroke1ADA2 CL E G H51816182410Idiopathic livedo reticularis with systemic involvement182410C0282492OMIM15331839607575
HP:0001297HP:0002326Transient ischemic attack1ADA2 CL E G H51816182410Idiopathic livedo reticularis with systemic involvement182410C0282492OMIM15331839607575
HP:0001297HP:0002401Stroke-like episode1APP CL E G H351324703ORPHA1506620104760
HP:0001297HP:0002401Stroke-like episode1APP CL E G H351100006ORPHA1506620104760
HP:0001297HP:0002326Transient ischemic attack1APP CL E G H351324713ORPHA1506620104760
HP:0001297HP:0033762Middle cerebral artery stroke1APP CL E G H351324703ORPHA1506620104760
HP:0001297HP:0002140Ischemic stroke1APP CL E G H351100006ORPHA1506620104760
HP:0001297HP:0002401Stroke-like episode1APP CL E G H351324708ORPHA1506620104760
HP:0001297HP:0033762Middle cerebral artery stroke1APP CL E G H351100006ORPHA1506620104760
HP:0001297HP:0002140Ischemic stroke1APP CL E G H351324703ORPHA1506620104760
HP:0001297HP:0002326Transient ischemic attack1APP CL E G H351324703ORPHA1506620104760
HP:0001297HP:0002140Ischemic stroke1APP CL E G H351324708ORPHA1506620104760
HP:0001297HP:0033762Middle cerebral artery stroke1APP CL E G H351324708ORPHA1506620104760
HP:0001297HP:0002326Transient ischemic attack1APP CL E G H351100006ORPHA1506620104760
HP:0001297HP:0002401Stroke-like episode1APP CL E G H351324713ORPHA1506620104760
HP:0001297HP:0002326Transient ischemic attack1APP CL E G H351324708ORPHA1506620104760
HP:0001297HP:0002140Ischemic stroke1APP CL E G H351324713ORPHA1506620104760
HP:0001297HP:0033762Middle cerebral artery stroke1APP CL E G H351324713ORPHA1506620104760
HP:0001297HP:0002140Ischemic stroke1APP CL E G H351605714Cerebral amyloid angiopathy, APP-related605714C2751536OMIM1506620104760
HP:0001297HP:0033762Middle cerebral artery stroke1APP CL E G H351605714Cerebral amyloid angiopathy, APP-related605714C2751536OMIM1506620104760
HP:0001297HP:0002326Transient ischemic attack1APP CL E G H351605714Cerebral amyloid angiopathy, APP-related605714C2751536OMIM1506620104760
HP:0001297HP:0002401Stroke-like episode1APP CL E G H351605714Cerebral amyloid angiopathy, APP-related605714C2751536OMIM1506620104760
HP:0001297HP:0002401Stroke-like episode1BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA1249961605681
HP:0001297HP:0002140Ischemic stroke1BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA1249961605681
HP:0001297HP:0033762Middle cerebral artery stroke1BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA1249961605681
HP:0001297HP:0002326Transient ischemic attack1BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA1249961605681
HP:0001297HP:0002140Ischemic stroke1CBS CL E G H875236200Homocystinuria due to CBS deficiency236200C3150344OMIM111201550613381
HP:0001297HP:0033762Middle cerebral artery stroke1CBS CL E G H875236200Homocystinuria due to CBS deficiency236200C3150344OMIM111201550613381
HP:0001297HP:0002326Transient ischemic attack1CBS CL E G H875236200Homocystinuria due to CBS deficiency236200C3150344OMIM111201550613381
HP:0001297HP:0002401Stroke-like episode1CBS CL E G H875236200Homocystinuria due to CBS deficiency236200C3150344OMIM111201550613381
HP:0001297HP:0002401Stroke-like episode1CCM2 CL E G H83605603284Cerebral cavernous malformations 2603284C1864041OMIM131021708607929
HP:0001297HP:0002140Ischemic stroke1CCM2 CL E G H83605603284Cerebral cavernous malformations 2603284C1864041OMIM131021708607929
HP:0001297HP:0033762Middle cerebral artery stroke1CCM2 CL E G H83605603284Cerebral cavernous malformations 2603284C1864041OMIM131021708607929
HP:0001297HP:0002326Transient ischemic attack1CCM2 CL E G H83605603284Cerebral cavernous malformations 2603284C1864041OMIM131021708607929
HP:0001297HP:0002401Stroke-like episode1CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA12292586603432
HP:0001297HP:0002140Ischemic stroke1CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA12292586603432
HP:0001297HP:0033762Middle cerebral artery stroke1CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA12292586603432
HP:0001297HP:0002326Transient ischemic attack1CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA12292586603432
HP:0001297HP:0002401Stroke-like episode1CST3 CL E G H1471100008ORPHA1542475604312
HP:0001297HP:0033762Middle cerebral artery stroke1CST3 CL E G H1471100008ORPHA1542475604312
HP:0001297HP:0002140Ischemic stroke1CST3 CL E G H1471100008ORPHA1542475604312
HP:0001297HP:0002326Transient ischemic attack1CST3 CL E G H1471100008ORPHA1542475604312
HP:0001297HP:0002401Stroke-like episode1CST3 CL E G H1471105150Hereditary cerebral amyloid angiopathy, Icelandic type105150C1527338OMIM1542475604312
HP:0001297HP:0033762Middle cerebral artery stroke1CST3 CL E G H1471105150Hereditary cerebral amyloid angiopathy, Icelandic type105150C1527338OMIM1542475604312
HP:0001297HP:0002140Ischemic stroke1CST3 CL E G H1471105150Hereditary cerebral amyloid angiopathy, Icelandic type105150C1527338OMIM1542475604312
HP:0001297HP:0002326Transient ischemic attack1CST3 CL E G H1471105150Hereditary cerebral amyloid angiopathy, Icelandic type105150C1527338OMIM1542475604312
HP:0001297HP:0002326Transient ischemic attack1ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA19663327130160
HP:0001297HP:0002401Stroke-like episode1ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA19663327130160
HP:0001297HP:0002140Ischemic stroke1ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA19663327130160
HP:0001297HP:0033762Middle cerebral artery stroke1ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA19663327130160
HP:0001297HP:0002401Stroke-like episode1FLNA CL E G H2316300049Periventricular nodular heterotopia 1300049C1848213OMIM130333754300017
HP:0001297HP:0002140Ischemic stroke1FLNA CL E G H2316300049Periventricular nodular heterotopia 1300049C1848213OMIM130333754300017
HP:0001297HP:0033762Middle cerebral artery stroke1FLNA CL E G H2316300049Periventricular nodular heterotopia 1300049C1848213OMIM130333754300017
HP:0001297HP:0002326Transient ischemic attack1FLNA CL E G H2316300049Periventricular nodular heterotopia 1300049C1848213OMIM130333754300017
HP:0001297HP:0002401Stroke-like episode1GNAQ CL E G H27763205LBWD syndromeORPHA1914390600998
HP:0001297HP:0033762Middle cerebral artery stroke1GNAQ CL E G H27763205LBWD syndromeORPHA1914390600998
HP:0001297HP:0002140Ischemic stroke1GNAQ CL E G H27763205LBWD syndromeORPHA1914390600998
HP:0001297HP:0002326Transient ischemic attack1GNAQ CL E G H27763205LBWD syndromeORPHA1914390600998
HP:0001297HP:0002140Ischemic stroke1GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA11784659601679
HP:0001297HP:0033762Middle cerebral artery stroke1GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA11784659601679
HP:0001297HP:0002326Transient ischemic attack1GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA11784659601679
HP:0001297HP:0002401Stroke-like episode1GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA11784659601679
HP:0001297HP:0002401Stroke-like episode1GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA12664661604318
HP:0001297HP:0033762Middle cerebral artery stroke1GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA12664661604318
HP:0001297HP:0002140Ischemic stroke1GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA12664661604318
HP:0001297HP:0002326Transient ischemic attack1GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA12664661604318
HP:0001297HP:0002140Ischemic stroke1GUCY1A1 CL E G H2982401945ORPHA11024685139396
HP:0001297HP:0033762Middle cerebral artery stroke1GUCY1A1 CL E G H2982401945ORPHA11024685139396
HP:0001297HP:0002326Transient ischemic attack1GUCY1A1 CL E G H2982401945ORPHA11024685139396
HP:0001297HP:0002401Stroke-like episode1GUCY1A1 CL E G H2982401945ORPHA11024685139396
HP:0001297HP:0002326Transient ischemic attack1GYS1 CL E G H2997611556Glycogen storage disease 0, muscle611556C1969054OMIM16074706138570
HP:0001297HP:0002401Stroke-like episode1GYS1 CL E G H2997611556Glycogen storage disease 0, muscle611556C1969054OMIM16074706138570
HP:0001297HP:0002140Ischemic stroke1GYS1 CL E G H2997611556Glycogen storage disease 0, muscle611556C1969054OMIM16074706138570
HP:0001297HP:0033762Middle cerebral artery stroke1GYS1 CL E G H2997611556Glycogen storage disease 0, muscle611556C1969054OMIM16074706138570
HP:0001297HP:0002326Transient ischemic attack1HBB CL E G H3043603903Hb SS disease603903C0002895OMIM116004827141900
HP:0001297HP:0002401Stroke-like episode1HBB CL E G H3043603903Hb SS disease603903C0002895OMIM116004827141900
HP:0001297HP:0002140Ischemic stroke1HBB CL E G H3043603903Hb SS disease603903C0002895OMIM116004827141900
HP:0001297HP:0033762Middle cerebral artery stroke1HBB CL E G H3043603903Hb SS disease603903C0002895OMIM116004827141900
HP:0001297HP:0002140Ischemic stroke1HTRA1 CL E G H5654600142Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy600142C1838577OMIM12859476602194
HP:0001297HP:0033762Middle cerebral artery stroke1HTRA1 CL E G H5654600142Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy600142C1838577OMIM12859476602194
HP:0001297HP:0002326Transient ischemic attack1HTRA1 CL E G H5654600142Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy600142C1838577OMIM12859476602194
HP:0001297HP:0002401Stroke-like episode1HTRA1 CL E G H5654600142Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy600142C1838577OMIM12859476602194
HP:0001297HP:0002401Stroke-like episode1JAG1 CL E G H182118450Alagille syndrome 1118450C1956125OMIM116056188601920
HP:0001297HP:0002140Ischemic stroke1JAG1 CL E G H182118450Alagille syndrome 1118450C1956125OMIM116056188601920
HP:0001297HP:0033762Middle cerebral artery stroke1JAG1 CL E G H182118450Alagille syndrome 1118450C1956125OMIM116056188601920
HP:0001297HP:0002326Transient ischemic attack1JAG1 CL E G H182118450Alagille syndrome 1118450C1956125OMIM116056188601920
HP:0001297HP:0002401Stroke-like episode1KCNQ1 CL E G H3784607554Atrial fibrillation, familial, 3607554C1837014OMIM122006294607542
HP:0001297HP:0033762Middle cerebral artery stroke1KCNQ1 CL E G H3784607554Atrial fibrillation, familial, 3607554C1837014OMIM122006294607542
HP:0001297HP:0002140Ischemic stroke1KCNQ1 CL E G H3784607554Atrial fibrillation, familial, 3607554C1837014OMIM122006294607542
HP:0001297HP:0002326Transient ischemic attack1KCNQ1 CL E G H3784607554Atrial fibrillation, familial, 3607554C1837014OMIM122006294607542
HP:0001297HP:0002401Stroke-like episode1LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA12326613601329
HP:0001297HP:0002140Ischemic stroke1LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA12326613601329
HP:0001297HP:0033762Middle cerebral artery stroke1LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA12326613601329
HP:0001297HP:0002326Transient ischemic attack1LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA12326613601329
HP:0001297HP:0002401Stroke-like episode1MTHFR CL E G H4524236250Homocysteinemia due to MTHFR deficiency236250C1856058OMIM17247436607093
HP:0001297HP:0002140Ischemic stroke1MTHFR CL E G H4524236250Homocysteinemia due to MTHFR deficiency236250C1856058OMIM17247436607093
HP:0001297HP:0033762Middle cerebral artery stroke1MTHFR CL E G H4524236250Homocysteinemia due to MTHFR deficiency236250C1856058OMIM17247436607093
HP:0001297HP:0002326Transient ischemic attack1MTHFR CL E G H4524236250Homocysteinemia due to MTHFR deficiency236250C1856058OMIM17247436607093
HP:0001297HP:0002326Transient ischemic attack1NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM113437883600276
HP:0001297HP:0002401Stroke-like episode1NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM113437883600276
HP:0001297HP:0002140Ischemic stroke1NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM113437883600276
HP:0001297HP:0033762Middle cerebral artery stroke1NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM113437883600276
HP:0001297HP:0002401Stroke-like episode1NPPA CL E G H4878615745Atrial standstill 2615745C3810401OMIM11827939108780
HP:0001297HP:0002140Ischemic stroke1NPPA CL E G H4878615745Atrial standstill 2615745C3810401OMIM11827939108780
HP:0001297HP:0033762Middle cerebral artery stroke1NPPA CL E G H4878615745Atrial standstill 2615745C3810401OMIM11827939108780
HP:0001297HP:0002326Transient ischemic attack1NPPA CL E G H4878615745Atrial standstill 2615745C3810401OMIM11827939108780
HP:0001297HP:0002401Stroke-like episode1PRKAG2 CL E G H51422194200Wolff-Parkinson-White pattern194200C0043202OMIM110799386602743
HP:0001297HP:0002140Ischemic stroke1PRKAG2 CL E G H51422194200Wolff-Parkinson-White pattern194200C0043202OMIM110799386602743
HP:0001297HP:0033762Middle cerebral artery stroke1PRKAG2 CL E G H51422194200Wolff-Parkinson-White pattern194200C0043202OMIM110799386602743
HP:0001297HP:0002326Transient ischemic attack1PRKAG2 CL E G H51422194200Wolff-Parkinson-White pattern194200C0043202OMIM110799386602743
HP:0001297HP:0002326Transient ischemic attack1RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA12009970600404
HP:0001297HP:0002401Stroke-like episode1RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA12009970600404
HP:0001297HP:0002140Ischemic stroke1RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA12009970600404
HP:0001297HP:0033762Middle cerebral artery stroke1RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA12009970600404
HP:0001297HP:0002401Stroke-like episode1SCN5A CL E G H6331601154Dilated cardiomyopathy 1E601154C1832680OMIM1353110593600163
HP:0001297HP:0002140Ischemic stroke1SCN5A CL E G H6331601154Dilated cardiomyopathy 1E601154C1832680OMIM1353110593600163
HP:0001297HP:0033762Middle cerebral artery stroke1SCN5A CL E G H6331601154Dilated cardiomyopathy 1E601154C1832680OMIM1353110593600163
HP:0001297HP:0002326Transient ischemic attack1SCN5A CL E G H6331601154Dilated cardiomyopathy 1E601154C1832680OMIM1353110593600163
HP:0001297HP:0002140Ischemic stroke1TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA119411586605842
HP:0001297HP:0033762Middle cerebral artery stroke1TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA119411586605842
HP:0001297HP:0002326Transient ischemic attack1TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA119411586605842
HP:0001297HP:0002401Stroke-like episode1TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA119411586605842
HP:0001297HP:0002401Stroke-like episode1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0001297HP:0002140Ischemic stroke1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0001297HP:0033762Middle cerebral artery stroke1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0001297HP:0002326Transient ischemic attack1TPP2 CL E G H7174444463ORPHA162512016190470
HP:0001297HP:0002140Ischemic stroke1TREX1 CL E G H11277247691ORPHA141812269606609
HP:0001297HP:0033762Middle cerebral artery stroke1TREX1 CL E G H11277247691ORPHA141812269606609
HP:0001297HP:0002326Transient ischemic attack1TREX1 CL E G H11277247691ORPHA141812269606609
HP:0001297HP:0002401Stroke-like episode1TREX1 CL E G H11277247691ORPHA141812269606609
HP:0001297HP:0002326Transient ischemic attack1TREX1 CL E G H11277192315Vasculopathy, retinal, with cerebral leukodystrophy192315C1860518OMIM141812269606609
HP:0001297HP:0002401Stroke-like episode1TREX1 CL E G H11277192315Vasculopathy, retinal, with cerebral leukodystrophy192315C1860518OMIM141812269606609
HP:0001297HP:0002140Ischemic stroke1TREX1 CL E G H11277192315Vasculopathy, retinal, with cerebral leukodystrophy192315C1860518OMIM141812269606609
HP:0001297HP:0033762Middle cerebral artery stroke1TREX1 CL E G H11277192315Vasculopathy, retinal, with cerebral leukodystrophy192315C1860518OMIM141812269606609
HP:0001297HP:0002140Ischemic stroke1VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM1180512687608537
HP:0001297HP:0033762Middle cerebral artery stroke1VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM1180512687608537
HP:0001297HP:0002326Transient ischemic attack1VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM1180512687608537
HP:0001297HP:0002401Stroke-like episode1VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM1180512687608537
HP:0001297HP:0032325Lacunar stroke2ABCC6 CL E G H368264800Pseudoxanthoma elasticum264800C0033847OMIM1166657603234
HP:0001297HP:0032325Lacunar stroke2ACAD9 CL E G H28976611126Acyl-CoA dehydrogenase family, member 9, deficiency of611126C1970173OMIM177121497611103
HP:0001297HP:0032325Lacunar stroke2ADA2 CL E G H51816182410Idiopathic livedo reticularis with systemic involvement182410C0282492OMIM15331839607575
HP:0001297HP:0032325Lacunar stroke2APP CL E G H351100006ORPHA1506620104760
HP:0001297HP:0032325Lacunar stroke2APP CL E G H351324703ORPHA1506620104760
HP:0001297HP:0032325Lacunar stroke2APP CL E G H351324708ORPHA1506620104760
HP:0001297HP:0032325Lacunar stroke2APP CL E G H351324713ORPHA1506620104760
HP:0001297HP:0032325Lacunar stroke2APP CL E G H351605714Cerebral amyloid angiopathy, APP-related605714C2751536OMIM1506620104760
HP:0001297HP:0032325Lacunar stroke2BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA1249961605681
HP:0001297HP:0032325Lacunar stroke2CBS CL E G H875236200Homocystinuria due to CBS deficiency236200C3150344OMIM111201550613381
HP:0001297HP:0032325Lacunar stroke2CCM2 CL E G H83605603284Cerebral cavernous malformations 2603284C1864041OMIM131021708607929
HP:0001297HP:0032325Lacunar stroke2CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA12292586603432
HP:0001297HP:0032325Lacunar stroke2CST3 CL E G H1471100008ORPHA1542475604312
HP:0001297HP:0032325Lacunar stroke2CST3 CL E G H1471105150Hereditary cerebral amyloid angiopathy, Icelandic type105150C1527338OMIM1542475604312
HP:0001297HP:0032325Lacunar stroke2ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA19663327130160
HP:0001297HP:0032325Lacunar stroke2FLNA CL E G H2316300049Periventricular nodular heterotopia 1300049C1848213OMIM130333754300017
HP:0001297HP:0032325Lacunar stroke2GNAQ CL E G H27763205LBWD syndromeORPHA1914390600998
HP:0001297HP:0032325Lacunar stroke2GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA11784659601679
HP:0001297HP:0032325Lacunar stroke2GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA12664661604318
HP:0001297HP:0032325Lacunar stroke2GUCY1A1 CL E G H2982401945ORPHA11024685139396
HP:0001297HP:0032325Lacunar stroke2GYS1 CL E G H2997611556Glycogen storage disease 0, muscle611556C1969054OMIM16074706138570
HP:0001297HP:0032325Lacunar stroke2HBB CL E G H3043603903Hb SS disease603903C0002895OMIM116004827141900
HP:0001297HP:0032325Lacunar stroke2HTRA1 CL E G H5654600142Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy600142C1838577OMIM12859476602194
HP:0001297HP:0032325Lacunar stroke2JAG1 CL E G H182118450Alagille syndrome 1118450C1956125OMIM116056188601920
HP:0001297HP:0032325Lacunar stroke2KCNQ1 CL E G H3784607554Atrial fibrillation, familial, 3607554C1837014OMIM122006294607542
HP:0001297HP:0032325Lacunar stroke2LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA12326613601329
HP:0001297HP:0032325Lacunar stroke2MTHFR CL E G H4524236250Homocysteinemia due to MTHFR deficiency236250C1856058OMIM17247436607093
HP:0001297HP:0032325Lacunar stroke2NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM113437883600276
HP:0001297HP:0032325Lacunar stroke2NPPA CL E G H4878615745Atrial standstill 2615745C3810401OMIM11827939108780
HP:0001297HP:0032325Lacunar stroke2PRKAG2 CL E G H51422194200Wolff-Parkinson-White pattern194200C0043202OMIM110799386602743
HP:0001297HP:0032325Lacunar stroke2RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA12009970600404
HP:0001297HP:0032325Lacunar stroke2SCN5A CL E G H6331601154Dilated cardiomyopathy 1E601154C1832680OMIM1353110593600163
HP:0001297HP:0032325Lacunar stroke2TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA119411586605842
HP:0001297HP:0032325Lacunar stroke2TPP2 CL E G H7174444463ORPHA162512016190470
HP:0001297HP:0032325Lacunar stroke2TREX1 CL E G H11277247691ORPHA141812269606609
HP:0001297HP:0032325Lacunar stroke2TREX1 CL E G H11277192315Vasculopathy, retinal, with cerebral leukodystrophy192315C1860518OMIM141812269606609
HP:0001297HP:0032325Lacunar stroke2VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM1180512687608537
HP:0001297HP:0032570Pontine ischemic lacunes3ABCC6 CL E G H368264800Pseudoxanthoma elasticum264800C0033847OMIM1166657603234
HP:0001297HP:0032570Pontine ischemic lacunes3ACAD9 CL E G H28976611126Acyl-CoA dehydrogenase family, member 9, deficiency of611126C1970173OMIM177121497611103
HP:0001297HP:0032570Pontine ischemic lacunes3ADA2 CL E G H51816182410Idiopathic livedo reticularis with systemic involvement182410C0282492OMIM15331839607575
HP:0001297HP:0032570Pontine ischemic lacunes3APP CL E G H351324708ORPHA1506620104760
HP:0001297HP:0032570Pontine ischemic lacunes3APP CL E G H351324713ORPHA1506620104760
HP:0001297HP:0032570Pontine ischemic lacunes3APP CL E G H351324703ORPHA1506620104760
HP:0001297HP:0032570Pontine ischemic lacunes3APP CL E G H351100006ORPHA1506620104760
HP:0001297HP:0032570Pontine ischemic lacunes3APP CL E G H351605714Cerebral amyloid angiopathy, APP-related605714C2751536OMIM1506620104760
HP:0001297HP:0032570Pontine ischemic lacunes3BAZ1B CL E G H9031904Blepharophimosis nasal groove growth retardationORPHA1249961605681
HP:0001297HP:0032570Pontine ischemic lacunes3CBS CL E G H875236200Homocystinuria due to CBS deficiency236200C3150344OMIM111201550613381
HP:0001297HP:0032570Pontine ischemic lacunes3CCM2 CL E G H83605603284Cerebral cavernous malformations 2603284C1864041OMIM131021708607929
HP:0001297HP:0032570Pontine ischemic lacunes3CLIP2 CL E G H7461904Blepharophimosis nasal groove growth retardationORPHA12292586603432
HP:0001297HP:0032570Pontine ischemic lacunes3CST3 CL E G H1471100008ORPHA1542475604312
HP:0001297HP:0032570Pontine ischemic lacunes3CST3 CL E G H1471105150Hereditary cerebral amyloid angiopathy, Icelandic type105150C1527338OMIM1542475604312
HP:0001297HP:0032570Pontine ischemic lacunes3ELN CL E G H2006904Blepharophimosis nasal groove growth retardationORPHA19663327130160
HP:0001297HP:0032570Pontine ischemic lacunes3FLNA CL E G H2316300049Periventricular nodular heterotopia 1300049C1848213OMIM130333754300017
HP:0001297HP:0032570Pontine ischemic lacunes3GNAQ CL E G H27763205LBWD syndromeORPHA1914390600998
HP:0001297HP:0032570Pontine ischemic lacunes3GTF2I CL E G H2969904Blepharophimosis nasal groove growth retardationORPHA11784659601679
HP:0001297HP:0032570Pontine ischemic lacunes3GTF2IRD1 CL E G H9569904Blepharophimosis nasal groove growth retardationORPHA12664661604318
HP:0001297HP:0032570Pontine ischemic lacunes3GUCY1A1 CL E G H2982401945ORPHA11024685139396
HP:0001297HP:0032570Pontine ischemic lacunes3GYS1 CL E G H2997611556Glycogen storage disease 0, muscle611556C1969054OMIM16074706138570
HP:0001297HP:0032570Pontine ischemic lacunes3HBB CL E G H3043603903Hb SS disease603903C0002895OMIM116004827141900
HP:0001297HP:0032570Pontine ischemic lacunes3HTRA1 CL E G H5654600142Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy600142C1838577OMIM12859476602194
HP:0001297HP:0032570Pontine ischemic lacunes3JAG1 CL E G H182118450Alagille syndrome 1118450C1956125OMIM116056188601920
HP:0001297HP:0032570Pontine ischemic lacunes3KCNQ1 CL E G H3784607554Atrial fibrillation, familial, 3607554C1837014OMIM122006294607542
HP:0001297HP:0032570Pontine ischemic lacunes3LIMK1 CL E G H3984904Blepharophimosis nasal groove growth retardationORPHA12326613601329
HP:0001297HP:0032570Pontine ischemic lacunes3MTHFR CL E G H4524236250Homocysteinemia due to MTHFR deficiency236250C1856058OMIM17247436607093
HP:0001297HP:0032570Pontine ischemic lacunes3NOTCH3 CL E G H4854125310Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy125310C0751587OMIM113437883600276
HP:0001297HP:0032570Pontine ischemic lacunes3NPPA CL E G H4878615745Atrial standstill 2615745C3810401OMIM11827939108780
HP:0001297HP:0032570Pontine ischemic lacunes3PRKAG2 CL E G H51422194200Wolff-Parkinson-White pattern194200C0043202OMIM110799386602743
HP:0001297HP:0032570Pontine ischemic lacunes3RFC2 CL E G H5982904Blepharophimosis nasal groove growth retardationORPHA12009970600404
HP:0001297HP:0032570Pontine ischemic lacunes3SCN5A CL E G H6331601154Dilated cardiomyopathy 1E601154C1832680OMIM1353110593600163
HP:0001297HP:0032570Pontine ischemic lacunes3TBL2 CL E G H26608904Blepharophimosis nasal groove growth retardationORPHA119411586605842
HP:0001297HP:0032570Pontine ischemic lacunes3TPP2 CL E G H7174444463ORPHA162512016190470
HP:0001297HP:0032570Pontine ischemic lacunes3TREX1 CL E G H11277247691ORPHA141812269606609
HP:0001297HP:0032570Pontine ischemic lacunes3TREX1 CL E G H11277192315Vasculopathy, retinal, with cerebral leukodystrophy192315C1860518OMIM141812269606609
HP:0001297HP:0032570Pontine ischemic lacunes3VHL CL E G H7428263400Erythrocytosis, familial, 2263400C1837915OMIM1180512687608537
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0001297HP:0001297Stroke0ADA2 CL E G H51816615688Polyarteritis nodosa, childhoood-onset615688C3887654OMIM05331839607575
HP:0001297HP:0001297Stroke0AGXT CL E G H18993598ORPHA0754341604285
HP:0001297HP:0001297Stroke0ASS1 CL E G H445215700Citrullinemia type I215700C0175683OMIM0686758603470
HP:0001297HP:0001297Stroke0COL4A1 CL E G H1282611773Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps611773C2673195OMIM017852202120130
HP:0001297HP:0001297Stroke0CPS1 CL E G H1373237300Congenital hyperammonemia, type I237300C0751753OMIM015072323608307
HP:0001297HP:0001297Stroke0CYP11B1 CL E G H158490795ORPHA07032591610613
HP:0001297HP:0001297Stroke0DYRK1B CL E G H9149615812Abdominal obesity-metabolic syndrome 3615812C4014361OMIM01083092604556
HP:0001297HP:0001297Stroke0ELN CL E G H2006194050Williams syndrome194050C0175702OMIM09663327130160
HP:0001297HP:0001297Stroke0JAK2 CL E G H3717729Anti-factor 8 autoimmunizationORPHA04126192147796
HP:0001297HP:0001297Stroke0MLXIPL CL E G H51085194050Williams syndrome194050C0175702OMIM024812744605678
HP:0001297HP:0001297Stroke0MMUT CL E G H459479312ORPHA08967526609058
HP:0001297HP:0001297Stroke0MPL CL E G H4352729Anti-factor 8 autoimmunizationORPHA05627217159530
HP:0001297HP:0001297Stroke0MYD88 CL E G H461533226ORPHA01417562602170
HP:0001297HP:0001297Stroke0MYH11 CL E G H4629229ORPHA029937569160745
HP:0001297HP:0001297Stroke0MYH11 CL E G H4629132900Aortic aneurysm, familial thoracic 4132900C1851504OMIM029937569160745
HP:0001297HP:0001297Stroke0NR3C1 CL E G H2908786Arthrogryposis multiplex congenita distalORPHA02097978138040
HP:0001297HP:0001297Stroke0OTC CL E G H5009311250Ornithine carbamoyltransferase deficiency311250C0268542OMIM09238512300461
HP:0001297HP:0001297Stroke0PCNT CL E G H51162637HemimegalencephalyORPHA0200116068605925
HP:0001297HP:0001297Stroke0SLC19A2 CL E G H1056049827ORPHA024610938603941
HP:0001297HP:0001297Stroke0SLC19A2 CL E G H10560249270Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness249270C0342287OMIM024610938603941
HP:0001297HP:0001297Stroke0SMAD4 CL E G H4089175050Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome175050C1832942OMIM018986770600993
HP:0001297HP:0001297Stroke0SNAP29 CL E G H934266631ORPHA065811133604202
HP:0001297HP:0001297Stroke0TET2 CL E G H54790729Anti-factor 8 autoimmunizationORPHA032625941612839
HP:0001297HP:0001297Stroke0TNXB CL E G H7148230839ORPHA0215911976600985
HP:0001297HP:0002401Stroke-like episode1ADA2 CL E G H51816615688Polyarteritis nodosa, childhoood-onset615688C3887654OMIM05331839607575
HP:0001297HP:0002140Ischemic stroke1ADA2 CL E G H51816615688Polyarteritis nodosa, childhoood-onset615688C3887654OMIM05331839607575
HP:0001297HP:0033762Middle cerebral artery stroke1ADA2 CL E G H51816615688Polyarteritis nodosa, childhoood-onset615688C3887654OMIM05331839607575
HP:0001297HP:0002326Transient ischemic attack1ADA2 CL E G H51816615688Polyarteritis nodosa, childhoood-onset615688C3887654OMIM05331839607575
HP:0001297HP:0002140Ischemic stroke1AGXT CL E G H18993598ORPHA0754341604285
HP:0001297HP:0033762Middle cerebral artery stroke1AGXT CL E G H18993598ORPHA0754341604285
HP:0001297HP:0002326Transient ischemic attack1AGXT CL E G H18993598ORPHA0754341604285
HP:0001297HP:0002401Stroke-like episode1AGXT CL E G H18993598ORPHA0754341604285
HP:0001297HP:0002326Transient ischemic attack1ASS1 CL E G H445215700Citrullinemia type I215700C0175683OMIM0686758603470
HP:0001297HP:0002401Stroke-like episode1ASS1 CL E G H445215700Citrullinemia type I215700C0175683OMIM0686758603470
HP:0001297HP:0002140Ischemic stroke1ASS1 CL E G H445215700Citrullinemia type I215700C0175683OMIM0686758603470
HP:0001297HP:0033762Middle cerebral artery stroke1ASS1 CL E G H445215700Citrullinemia type I215700C0175683OMIM0686758603470
HP:0001297HP:0002140Ischemic stroke1COL4A1 CL E G H1282611773Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps611773C2673195OMIM017852202120130
HP:0001297HP:0033762Middle cerebral artery stroke1COL4A1 CL E G H1282611773Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps611773C2673195OMIM017852202120130
HP:0001297HP:0002326Transient ischemic attack1COL4A1 CL E G H1282611773Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps611773C2673195OMIM017852202120130
HP:0001297HP:0002401Stroke-like episode1COL4A1 CL E G H1282611773Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps611773C2673195OMIM017852202120130
HP:0001297HP:0002401Stroke-like episode1CPS1 CL E G H1373237300Congenital hyperammonemia, type I237300C0751753OMIM015072323608307
HP:0001297HP:0002140Ischemic stroke1CPS1 CL E G H1373237300Congenital hyperammonemia, type I237300C0751753OMIM015072323608307
HP:0001297HP:0033762Middle cerebral artery stroke1CPS1 CL E G H1373237300Congenital hyperammonemia, type I237300C0751753OMIM015072323608307
HP:0001297HP:0002326Transient ischemic attack1CPS1 CL E G H1373237300Congenital hyperammonemia, type I237300C0751753OMIM015072323608307
HP:0001297HP:0002326Transient ischemic attack1CYP11B1 CL E G H158490795ORPHA07032591610613
HP:0001297HP:0002401Stroke-like episode1CYP11B1 CL E G H158490795ORPHA07032591610613
HP:0001297HP:0002140Ischemic stroke1CYP11B1 CL E G H158490795ORPHA07032591610613
HP:0001297HP:0033762Middle cerebral artery stroke1CYP11B1 CL E G H158490795ORPHA07032591610613
HP:0001297HP:0002326Transient ischemic attack1DYRK1B CL E G H9149615812Abdominal obesity-metabolic syndrome 3615812C4014361OMIM01083092604556
HP:0001297HP:0002401Stroke-like episode1DYRK1B CL E G H9149615812Abdominal obesity-metabolic syndrome 3615812C4014361OMIM01083092604556
HP:0001297HP:0002140Ischemic stroke1DYRK1B CL E G H9149615812Abdominal obesity-metabolic syndrome 3615812C4014361OMIM01083092604556
HP:0001297HP:0033762Middle cerebral artery stroke1DYRK1B CL E G H9149615812Abdominal obesity-metabolic syndrome 3615812C4014361OMIM01083092604556
HP:0001297HP:0002140Ischemic stroke1ELN CL E G H2006194050Williams syndrome194050C0175702OMIM09663327130160
HP:0001297HP:0033762Middle cerebral artery stroke1ELN CL E G H2006194050Williams syndrome194050C0175702OMIM09663327130160
HP:0001297HP:0002326Transient ischemic attack1ELN CL E G H2006194050Williams syndrome194050C0175702OMIM09663327130160
HP:0001297HP:0002401Stroke-like episode1ELN CL E G H2006194050Williams syndrome194050C0175702OMIM09663327130160
HP:0001297HP:0002401Stroke-like episode1JAK2 CL E G H3717729Anti-factor 8 autoimmunizationORPHA04126192147796
HP:0001297HP:0033762Middle cerebral artery stroke1JAK2 CL E G H3717729Anti-factor 8 autoimmunizationORPHA04126192147796
HP:0001297HP:0002140Ischemic stroke1JAK2 CL E G H3717729Anti-factor 8 autoimmunizationORPHA04126192147796
HP:0001297HP:0002326Transient ischemic attack1JAK2 CL E G H3717729Anti-factor 8 autoimmunizationORPHA04126192147796
HP:0001297HP:0002401Stroke-like episode1MLXIPL CL E G H51085194050Williams syndrome194050C0175702OMIM024812744605678
HP:0001297HP:0033762Middle cerebral artery stroke1MLXIPL CL E G H51085194050Williams syndrome194050C0175702OMIM024812744605678
HP:0001297HP:0002140Ischemic stroke1MLXIPL CL E G H51085194050Williams syndrome194050C0175702OMIM024812744605678
HP:0001297HP:0002326Transient ischemic attack1MLXIPL CL E G H51085194050Williams syndrome194050C0175702OMIM024812744605678
HP:0001297HP:0002401Stroke-like episode1MMUT CL E G H459479312ORPHA08967526609058
HP:0001297HP:0002140Ischemic stroke1MMUT CL E G H459479312ORPHA08967526609058
HP:0001297HP:0033762Middle cerebral artery stroke1MMUT CL E G H459479312ORPHA08967526609058
HP:0001297HP:0002326Transient ischemic attack1MMUT CL E G H459479312ORPHA08967526609058
HP:0001297HP:0002401Stroke-like episode1MPL CL E G H4352729Anti-factor 8 autoimmunizationORPHA05627217159530
HP:0001297HP:0002140Ischemic stroke1MPL CL E G H4352729Anti-factor 8 autoimmunizationORPHA05627217159530
HP:0001297HP:0033762Middle cerebral artery stroke1MPL CL E G H4352729Anti-factor 8 autoimmunizationORPHA05627217159530
HP:0001297HP:0002326Transient ischemic attack1MPL CL E G H4352729Anti-factor 8 autoimmunizationORPHA05627217159530
HP:0001297HP:0002326Transient ischemic attack1MYD88 CL E G H461533226ORPHA01417562602170
HP:0001297HP:0002401Stroke-like episode1MYD88 CL E G H461533226ORPHA01417562602170
HP:0001297HP:0002140Ischemic stroke1MYD88 CL E G H461533226ORPHA01417562602170
HP:0001297HP:0033762Middle cerebral artery stroke1MYD88 CL E G H461533226ORPHA01417562602170
HP:0001297HP:0002140Ischemic stroke1MYH11 CL E G H4629229ORPHA029937569160745
HP:0001297HP:0033762Middle cerebral artery stroke1MYH11 CL E G H4629229ORPHA029937569160745
HP:0001297HP:0002326Transient ischemic attack1MYH11 CL E G H4629229ORPHA029937569160745
HP:0001297HP:0002401Stroke-like episode1MYH11 CL E G H4629229ORPHA029937569160745
HP:0001297HP:0033762Middle cerebral artery stroke1MYH11 CL E G H4629132900Aortic aneurysm, familial thoracic 4132900C1851504OMIM029937569160745
HP:0001297HP:0002140Ischemic stroke1MYH11 CL E G H4629132900Aortic aneurysm, familial thoracic 4132900C1851504OMIM029937569160745
HP:0001297HP:0002326Transient ischemic attack1MYH11 CL E G H4629132900Aortic aneurysm, familial thoracic 4132900C1851504OMIM029937569160745
HP:0001297HP:0002401Stroke-like episode1MYH11 CL E G H4629132900Aortic aneurysm, familial thoracic 4132900C1851504OMIM029937569160745
HP:0001297HP:0002140Ischemic stroke1NR3C1 CL E G H2908786Arthrogryposis multiplex congenita distalORPHA02097978138040
HP:0001297HP:0033762Middle cerebral artery stroke1NR3C1 CL E G H2908786Arthrogryposis multiplex congenita distalORPHA02097978138040
HP:0001297HP:0002326Transient ischemic attack1NR3C1 CL E G H2908786Arthrogryposis multiplex congenita distalORPHA02097978138040
HP:0001297HP:0002401Stroke-like episode1NR3C1 CL E G H2908786Arthrogryposis multiplex congenita distalORPHA02097978138040
HP:0001297HP:0002326Transient ischemic attack1OTC CL E G H5009311250Ornithine carbamoyltransferase deficiency311250C0268542OMIM09238512300461
HP:0001297HP:0002401Stroke-like episode1OTC CL E G H5009311250Ornithine carbamoyltransferase deficiency311250C0268542OMIM09238512300461
HP:0001297HP:0002140Ischemic stroke1OTC CL E G H5009311250Ornithine carbamoyltransferase deficiency311250C0268542OMIM09238512300461
HP:0001297HP:0033762Middle cerebral artery stroke1OTC CL E G H5009311250Ornithine carbamoyltransferase deficiency311250C0268542OMIM09238512300461
HP:0001297HP:0002401Stroke-like episode1PCNT CL E G H51162637HemimegalencephalyORPHA0200116068605925
HP:0001297HP:0002140Ischemic stroke1PCNT CL E G H51162637HemimegalencephalyORPHA0200116068605925
HP:0001297HP:0033762Middle cerebral artery stroke1PCNT CL E G H51162637HemimegalencephalyORPHA0200116068605925
HP:0001297HP:0002326Transient ischemic attack1PCNT CL E G H51162637HemimegalencephalyORPHA0200116068605925
HP:0001297HP:0002140Ischemic stroke1SLC19A2 CL E G H1056049827ORPHA024610938603941
HP:0001297HP:0033762Middle cerebral artery stroke1SLC19A2 CL E G H1056049827ORPHA024610938603941
HP:0001297HP:0002326Transient ischemic attack1SLC19A2 CL E G H1056049827ORPHA024610938603941
HP:0001297HP:0002401Stroke-like episode1SLC19A2 CL E G H1056049827ORPHA024610938603941
HP:0001297HP:0002326Transient ischemic attack1SLC19A2 CL E G H10560249270Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness249270C0342287OMIM024610938603941
HP:0001297HP:0002401Stroke-like episode1SLC19A2 CL E G H10560249270Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness249270C0342287OMIM024610938603941
HP:0001297HP:0002140Ischemic stroke1SLC19A2 CL E G H10560249270Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness249270C0342287OMIM024610938603941
HP:0001297HP:0033762Middle cerebral artery stroke1SLC19A2 CL E G H10560249270Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness249270C0342287OMIM024610938603941
HP:0001297HP:0002401Stroke-like episode1SMAD4 CL E G H4089175050Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome175050C1832942OMIM018986770600993
HP:0001297HP:0002140Ischemic stroke1SMAD4 CL E G H4089175050Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome175050C1832942OMIM018986770600993
HP:0001297HP:0033762Middle cerebral artery stroke1SMAD4 CL E G H4089175050Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome175050C1832942OMIM018986770600993
HP:0001297HP:0002326Transient ischemic attack1SMAD4 CL E G H4089175050Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome175050C1832942OMIM018986770600993
HP:0001297HP:0002401Stroke-like episode1SNAP29 CL E G H934266631ORPHA065811133604202
HP:0001297HP:0033762Middle cerebral artery stroke1SNAP29 CL E G H934266631ORPHA065811133604202
HP:0001297HP:0002140Ischemic stroke1SNAP29 CL E G H934266631ORPHA065811133604202
HP:0001297HP:0002326Transient ischemic attack1SNAP29 CL E G H934266631ORPHA065811133604202
HP:0001297HP:0002326Transient ischemic attack1TET2 CL E G H54790729Anti-factor 8 autoimmunizationORPHA032625941612839
HP:0001297HP:0002401Stroke-like episode1TET2 CL E G H54790729Anti-factor 8 autoimmunizationORPHA032625941612839
HP:0001297HP:0002140Ischemic stroke1TET2 CL E G H54790729Anti-factor 8 autoimmunizationORPHA032625941612839
HP:0001297HP:0033762Middle cerebral artery stroke1TET2 CL E G H54790729Anti-factor 8 autoimmunizationORPHA032625941612839
HP:0001297HP:0002326Transient ischemic attack1TNXB CL E G H7148230839ORPHA0215911976600985
HP:0001297HP:0002401Stroke-like episode1TNXB CL E G H7148230839ORPHA0215911976600985
HP:0001297HP:0002140Ischemic stroke1TNXB CL E G H7148230839ORPHA0215911976600985
HP:0001297HP:0033762Middle cerebral artery stroke1TNXB CL E G H7148230839ORPHA0215911976600985
HP:0001297HP:0032325Lacunar stroke2ADA2 CL E G H51816615688Polyarteritis nodosa, childhoood-onset615688C3887654OMIM05331839607575
HP:0001297HP:0032325Lacunar stroke2AGXT CL E G H18993598ORPHA0754341604285
HP:0001297HP:0032325Lacunar stroke2ASS1 CL E G H445215700Citrullinemia type I215700C0175683OMIM0686758603470
HP:0001297HP:0032325Lacunar stroke2COL4A1 CL E G H1282611773Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps611773C2673195OMIM017852202120130
HP:0001297HP:0032325Lacunar stroke2CPS1 CL E G H1373237300Congenital hyperammonemia, type I237300C0751753OMIM015072323608307
HP:0001297HP:0032325Lacunar stroke2CYP11B1 CL E G H158490795ORPHA07032591610613
HP:0001297HP:0032325Lacunar stroke2DYRK1B CL E G H9149615812Abdominal obesity-metabolic syndrome 3615812C4014361OMIM01083092604556
HP:0001297HP:0032325Lacunar stroke2ELN CL E G H2006194050Williams syndrome194050C0175702OMIM09663327130160
HP:0001297HP:0032325Lacunar stroke2JAK2 CL E G H3717729Anti-factor 8 autoimmunizationORPHA04126192147796
HP:0001297HP:0032325Lacunar stroke2MLXIPL CL E G H51085194050Williams syndrome194050C0175702OMIM024812744605678
HP:0001297HP:0032325Lacunar stroke2MMUT CL E G H459479312ORPHA08967526609058
HP:0001297HP:0032325Lacunar stroke2MPL CL E G H4352729Anti-factor 8 autoimmunizationORPHA05627217159530
HP:0001297HP:0032325Lacunar stroke2MYD88 CL E G H461533226ORPHA01417562602170
HP:0001297HP:0032325Lacunar stroke2MYH11 CL E G H4629229ORPHA029937569160745
HP:0001297HP:0032325Lacunar stroke2MYH11 CL E G H4629132900Aortic aneurysm, familial thoracic 4132900C1851504OMIM029937569160745
HP:0001297HP:0032325Lacunar stroke2NR3C1 CL E G H2908786Arthrogryposis multiplex congenita distalORPHA02097978138040
HP:0001297HP:0032325Lacunar stroke2OTC CL E G H5009311250Ornithine carbamoyltransferase deficiency311250C0268542OMIM09238512300461
HP:0001297HP:0032325Lacunar stroke2PCNT CL E G H51162637HemimegalencephalyORPHA0200116068605925
HP:0001297HP:0032325Lacunar stroke2SLC19A2 CL E G H1056049827ORPHA024610938603941
HP:0001297HP:0032325Lacunar stroke2SLC19A2 CL E G H10560249270Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness249270C0342287OMIM024610938603941
HP:0001297HP:0032325Lacunar stroke2SMAD4 CL E G H4089175050Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome175050C1832942OMIM018986770600993
HP:0001297HP:0032325Lacunar stroke2SNAP29 CL E G H934266631ORPHA065811133604202
HP:0001297HP:0032325Lacunar stroke2TET2 CL E G H54790729Anti-factor 8 autoimmunizationORPHA032625941612839
HP:0001297HP:0032325Lacunar stroke2TNXB CL E G H7148230839ORPHA0215911976600985
HP:0001297HP:0032570Pontine ischemic lacunes3ADA2 CL E G H51816615688Polyarteritis nodosa, childhoood-onset615688C3887654OMIM05331839607575
HP:0001297HP:0032570Pontine ischemic lacunes3AGXT CL E G H18993598ORPHA0754341604285
HP:0001297HP:0032570Pontine ischemic lacunes3ASS1 CL E G H445215700Citrullinemia type I215700C0175683OMIM0686758603470
HP:0001297HP:0032570Pontine ischemic lacunes3COL4A1 CL E G H1282611773Angiopathy, hereditary, with nephropathy, aneurysms, and muscle cramps611773C2673195OMIM017852202120130
HP:0001297HP:0032570Pontine ischemic lacunes3CPS1 CL E G H1373237300Congenital hyperammonemia, type I237300C0751753OMIM015072323608307
HP:0001297HP:0032570Pontine ischemic lacunes3CYP11B1 CL E G H158490795ORPHA07032591610613
HP:0001297HP:0032570Pontine ischemic lacunes3DYRK1B CL E G H9149615812Abdominal obesity-metabolic syndrome 3615812C4014361OMIM01083092604556
HP:0001297HP:0032570Pontine ischemic lacunes3ELN CL E G H2006194050Williams syndrome194050C0175702OMIM09663327130160
HP:0001297HP:0032570Pontine ischemic lacunes3JAK2 CL E G H3717729Anti-factor 8 autoimmunizationORPHA04126192147796
HP:0001297HP:0032570Pontine ischemic lacunes3MLXIPL CL E G H51085194050Williams syndrome194050C0175702OMIM024812744605678
HP:0001297HP:0032570Pontine ischemic lacunes3MMUT CL E G H459479312ORPHA08967526609058
HP:0001297HP:0032570Pontine ischemic lacunes3MPL CL E G H4352729Anti-factor 8 autoimmunizationORPHA05627217159530
HP:0001297HP:0032570Pontine ischemic lacunes3MYD88 CL E G H461533226ORPHA01417562602170
HP:0001297HP:0032570Pontine ischemic lacunes3MYH11 CL E G H4629229ORPHA029937569160745
HP:0001297HP:0032570Pontine ischemic lacunes3MYH11 CL E G H4629132900Aortic aneurysm, familial thoracic 4132900C1851504OMIM029937569160745
HP:0001297HP:0032570Pontine ischemic lacunes3NR3C1 CL E G H2908786Arthrogryposis multiplex congenita distalORPHA02097978138040
HP:0001297HP:0032570Pontine ischemic lacunes3OTC CL E G H5009311250Ornithine carbamoyltransferase deficiency311250C0268542OMIM09238512300461
HP:0001297HP:0032570Pontine ischemic lacunes3PCNT CL E G H51162637HemimegalencephalyORPHA0200116068605925
HP:0001297HP:0032570Pontine ischemic lacunes3SLC19A2 CL E G H1056049827ORPHA024610938603941
HP:0001297HP:0032570Pontine ischemic lacunes3SLC19A2 CL E G H10560249270Megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness249270C0342287OMIM024610938603941
HP:0001297HP:0032570Pontine ischemic lacunes3SMAD4 CL E G H4089175050Juvenile polyposis/hereditary hemorrhagic telangiectasia syndrome175050C1832942OMIM018986770600993
HP:0001297HP:0032570Pontine ischemic lacunes3SNAP29 CL E G H934266631ORPHA065811133604202
HP:0001297HP:0032570Pontine ischemic lacunes3TET2 CL E G H54790729Anti-factor 8 autoimmunizationORPHA032625941612839
HP:0001297HP:0032570Pontine ischemic lacunes3TNXB CL E G H7148230839ORPHA0215911976600985


Genes (109) :ABCC6 ACAD9 ACTA2 ACTB ACTG1 ACVRL1 ADA2 AGXT ANGPTL6 APP ASS1 BAZ1B CALR CBS CCM2 CLIP2 COL3A1 COL4A1 COL5A1 COX1 COX2 COX3 CPS1 CST3 CYP11B1 CYTB DPM3 DYRK1B ELN ENG FBN1 FLNA FOXE3 GDF2 GLA GNAQ GTF2I GTF2IRD1 GUCY1A1 GYS1 HBB HTRA1 JAG1 JAK2 KCNQ1 LIMK1 LMNA LOX MAT2A MFAP5 MLXIPL MMUT MPL MTHFR MYD88 MYH11 MYLK ND1 ND4 ND5 ND6 NOTCH3 NPPA NR3C1 OTC PCNT PIGA PMM2 PRKAG2 PRKG1 PRNP RFC2 RFT1 SCN5A SH2B3 SLC19A2 SLC2A10 SMAD3 SMAD4 SMARCAL1 SNAP29 SON STIM1 TBL2 TET2 TGFB2 TGFB3 TGFBR1 TGFBR2 TGFBR3 THPO TNXB TP53 TPP2 TREX1 TRNC TRNF TRNH TRNK TRNL1 TRNQ TRNS1 TRNS2 TRNV TRNW TTR VHL WFS1 ZMPSTE24

Diseases (79) :264800 611126 182410 615688 93598 100006 324713 324703 324708 605714 215700 904 236200 603284 611773 237300 100008 105150 90795 615812 194050 300049 3205 401945 611556 603903 600142 118450 729 607554 79312 236250 33226 229 132900 125310 615745 786 311250 2637 194200 601154 49827 249270 175050 66631 230839 444463 247691 192315 263400 91387 2995 774 600376 231160 3318 286 175780 550 540000 263494 187300 301500 324 615750 616779 71493 740 447 212065 282166 244310 208050 242900 500150 185070 105210 222300
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is August 2021 release.